INDEMNIFICATION AGREEMENTIndemnification Agreement • September 18th, 2018 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [ ], 2018 between Entasis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
] Shares Entasis Therapeutics Holdings Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 18th, 2018 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • New York
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
EMPLOYMENT AGREEMENTEmployment Agreement • September 18th, 2018 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Massachusetts
This EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of , 2018, by and between Mike Gutch (“Executive”) and Entasis Therapeutics Holdings Inc. (the “Company”), and which shall become effective upon the effectiveness of the registration statement for the Company’s initial public offering (the “Effective Date”).
ENTASIS THERAPEUTICS HOLDINGS INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 18th, 2018 • Entasis Therapeutics Holdings Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 14th day of September, 2018, by and among Entasis Therapeutics Holdings Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and the investors listed on Schedule A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
